🇺🇸 SAPHNELO in United States

SAPHNELO (ANIFROLUMAB-FNIA) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

SAPHNELO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is SAPHNELO approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for SAPHNELO in United States?

ASTRAZENECA AB is the originator. The local marketing authorisation holder may differ — check the official source linked above.